阿尔茨海默

• Cyclo Therapeutics Announces Closing of Underwriters’ Option to Purchase Additional Shares of Common Stock in Connection with its Underwritten Public Offering 2020-12-23
• Cyclo Therapeutics Announces Pricing of $12.5 Million Public Offering 2020-12-10
• Athira Pharma Awarded $15 Million Grant from National Institute on Aging to Support ACT-AD Clinical Trial in Alzheimer’s Disease 2020-12-08
• Cognoptix Revitalizes, Appoints New Chief Executive Officer Dr. Susanne Wilke, PhD, Raises Oversubscribed $2.6m Series R 2020-09-28
• Athira Pharma Announces Pricing of Initial Public Offering 2020-09-18
• Cantabio Pharmaceuticals receives grant from Michael J. Fox Foundation to develop a novel DJ-1 protein-based biomarker for Parkinson's Disease 2020-09-17
• Oligomerix Receives $3.19 Million NIH Commercialization Readiness Pilot Grant for Alzheimer's Disease Therapy 2020-09-15
• Cyclo Therapeutics Closes $2.8 Million Private Placement Led by Novit LP With $1.0 Million 2020-08-27
• Seattle’s Athira Pharma files for IPO to fund quest for Alzheimer’s and Parkinson’s breakthroughs 2020-08-27
• The Brain Protection Company Awarded $1M Research Grant To Pursue Novel Approach To Treat Alzheimer's Disease 2020-08-25

登录医药魔方官网 查看更多资讯